Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 19, 2021 - Issue 1
Submit an article Journal homepage
1,257
Views
1
CrossRef citations to date
0
Altmetric
Letter to the editor

Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

Chia Siang Kowa School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia
&
Syed Shahzad Hasanb Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom;c School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, AustraliaCorrespondence[email protected]
Pages 99-100 | Received 17 Aug 2020, Accepted 30 Sep 2020, Published online: 12 Nov 2020

References

  • Bottino LG, Fuchs FD. The role of angiotensin receptor blockers in CVD risk management. Expert Rev Cardiovasc Ther. 2020;18(4):181–185.
  • Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363(9426):2022–2031.
  • Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet. 2004;363(9426):2049–2051.
  • ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358(15):1547–1559.
  • Bangalore S, Kumar S, Wetterslev J, et al. Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials. BMJ. 2011;342:d2234.
  • Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs–overview and meta-analyses. J Hypertens. 2015;33(2):195–211.
  • Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses. J Hypertens. 2015;33(7):1321–1341.
  • Unger T, Borghi C, Charchar F, et al. 2020 international society of hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004.
  • Hasan SS, Kow CS, Hadi MA, et al. Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis [published online ahead of print, 2020 Sep 12]. Am J Cardiovasc Drugs. 2020. DOI:10.1007/s40256-020-00439-5
  • Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 1997;23(7):793–796.
  • Gandhi J, Jones R, Teubner D, et al. Multicentre audit of ACE-inhibitor associated angioedema (MAAAA). Aust Fam Physician. 2015;44(8):579–583.
  • Beavers CJ, Dunn SP, Macaulay TE. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother. 2011;45(4):520–524.
  • Makani H, Messerli FH, Romero J, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol. 2012;110(3):383–391.
  • Grewal E, Sutarjono B, Mohammed I. Angioedema, ACE inhibitor and COVID-19. BMJ Case Rep. 2020;13(9):e237888.
  • Cohen AJ, DiFrancesco MF, Solomon SD, et al. Angioedema in COVID-19. Eur Heart J. 2020;41(34):3283–3284.
  • Hoover T, Lippmann M, Grouzmann E, et al. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy. 2010;40(1):50–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.